Sun Pharma.Inds.

Part of MojoOne Strategy

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE044A01036
NSEID: SUNPHARMA
BSEID: 524715

INR

1,722.10

2.9 (0.17%)

BSENSE

Dec 29

BSE+NSE Vol: 7.53 lacs

Click here to access the older version

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,722.10",
    "chg": 2.9,
    "chgp": "0.17%",
    "dir": 1,
    "prev_price": "1,719.20",
    "mcapval": "413,189.48 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE044A01036",
    "curr_date": "Dec 29",
    "curr_time": "",
    "bse_nse_vol": "7.53 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 29, 2025",
    "traded_date_str": "2025 12 29",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3772772",
        "imagepath": "",
        "date": "2025-12-29 09:21:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the most influential and liquid stocks on the National Stock Exchange of India. This membership not only reflects the company’s sizeable market capitalisation—currently standing at approximately ₹4,12,145.76 crores—but also ensures its shares are closely tracked by institutional investors and index funds. The inclusion in this benchmark index often results in enhanced visibility and trading volumes, which can impact price discovery and investor sentiment.</p>\n                <p>Sun Pharma’s role within the Pharmaceuticals & Biotechnology sector is particularly noteworthy. The sector itself has seen a mixed set of results recently, with..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-3772236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_mojoScore_3772236.png",
        "date": "2025-12-28 10:10:03",
        "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 16 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-put-option-activity-amid-bearish-sentiment-3770552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_most_active_stocks_puts_3770552.png",
        "date": "2025-12-26 11:00:11",
        "description": "Sun Pharmaceutical Industries Ltd has emerged as a focal point in the derivatives market with significant put option activity observed ahead of the 30 December 2025 expiry. This surge in put contracts highlights a notable positioning among investors, reflecting cautious sentiment amid recent price movements and sector dynamics."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-challenges-amidst-nifty-50-membership-3770289",
        "imagepath": "",
        "date": "2025-12-26 09:21:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the broader Indian equity market. This membership not only underscores the company’s market capitalisation stature—currently valued at approximately ₹4,14,605 crore—but also ensures heightened visibility among institutional investors and index funds. The inclusion in this benchmark index often results in increased liquidity and trading volumes, as many passive funds track the Nifty 50 composition closely.</p>\n                <p>Sun Pharma’s role within the index is particularly important given the Pharmaceuticals & Biotechnology sector’s contribution to the Indian economy and healthcare..."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-amid-mixed-price-action-3768330",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_oi_spurts_by_underlying_3768330.png",
        "date": "2025-12-24 15:00:42",
        "description": "Sun Pharmaceutical Industries has experienced a significant rise in open interest within its derivatives segment, reflecting evolving market positioning and investor sentiment amid recent price fluctuations and sector dynamics."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-amid-mixed-price-action-3768267",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_oi_spurts_by_underlying_3768267.png",
        "date": "2025-12-24 14:00:26",
        "description": "Sun Pharmaceutical Industries has registered a significant rise in open interest within its derivatives segment, reflecting evolving market positioning and investor sentiment. This development comes amid a backdrop of subdued price performance and shifting volume dynamics, offering insights into potential directional bets and trading strategies in the pharmaceutical sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-amid-mixed-market-signals-3768213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaceutic_oi_spurts_by_underlying_3768213.png",
        "date": "2025-12-24 13:00:19",
        "description": "Sun Pharmaceutical Industries has experienced a significant rise in open interest within its derivatives segment, reflecting evolving market positioning and investor sentiment. This development comes amid a backdrop of recent price fluctuations and shifting volume patterns, offering insights into potential directional bets in the pharmaceutical sector."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-performance-3767916",
        "imagepath": "",
        "date": "2025-12-24 09:21:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Sun Pharmaceutical Industries under the spotlight of institutional investors and index funds, which often track or benchmark against this key market indicator. The company’s market capitalisation, currently standing at approximately ₹4,21,491 crore, solidifies its status as a large-cap entity within the Pharmaceuticals & Biotechnology sector. This inclusion not only enhances visibility but also influences liquidity and trading volumes, as many passive funds allocate capital in line with the index composition.</p>\n\n                <p>Sun Pharmaceutical’s presence in the Nifty 50 also means that its stock performance contributes materially to the overall index mov..."
      },
      {
        "title": "Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-navigating-nifty-50-membership-amid-mixed-market-performance-3766726",
        "imagepath": "",
        "date": "2025-12-23 09:21:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index, Sun Pharmaceutical Industries commands considerable attention from institutional investors and fund managers who track this benchmark closely. The company’s large-cap status, with a market capitalisation of approximately ₹4,24,982 crores, places it among the most influential stocks shaping the index’s trajectory. This membership not only enhances liquidity but also ensures that the stock is a key component in passive investment strategies and index funds.</p>\n                <p>Sun Pharma’s presence in the index reflects its scale and market relevance within the Pharmaceuticals & Biotechnology sector, which is a vital segment of the Indian economy. The sector itself has seen m..."
      }
    ],
    "total": 921,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "26-Dec-2025",
      "details": "SPIL Investor Presentation -Dec 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-Dec-2025",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - US FDA Determines Baska Facility Inspection Classification As OAI",
      "datetime": "18-Dec-2025",
      "details": "US FDA determines Baska facility inspection classification as OAI",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>550%</strong> dividend, ex-date: 07 Jul 25",
          "dt": "2025-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-29 09:21:48

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries among the most influential and liquid stocks on the National Stock Exchange of India. This membership not only reflects the company’s sizeable market capitalisation—currently standing at approximately ₹4,12,145.76 crores—but also ensures its shares are closely tracked by institutional investors and index funds. The inclusion in this benchmark index often results in enhanced visibility and trading volumes, which can impact price discovery and investor sentiment.

Sun Pharma’s role within the Pharmaceuticals & Biotechnology sector is particularly noteworthy. The sector itself has seen a mixed set of results recently, with...

Sun Pharmaceutical Industries Ltd is Rated Buy

2025-12-28 10:10:03

Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 16 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 December 2025, providing investors with the most up-to-date insight into the company’s performance and outlook.

Sun Pharmaceutical Industries Sees Heavy Put Option Activity Ahead of December Expiry

2025-12-26 11:00:11

Sun Pharmaceutical Industries Ltd has emerged as a focal point in the derivatives market with significant put option activity observed ahead of the 30 December 2025 expiry. This surge in put contracts highlights a notable positioning among investors, reflecting cautious sentiment amid recent price movements and sector dynamics.

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-26 09:21:23

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Sun Pharmaceutical Industries in a select group of large-cap companies that represent the broader Indian equity market. This membership not only underscores the company’s market capitalisation stature—currently valued at approximately ₹4,14,605 crore—but also ensures heightened visibility among institutional investors and index funds. The inclusion in this benchmark index often results in increased liquidity and trading volumes, as many passive funds track the Nifty 50 composition closely.

Sun Pharma’s role within the index is particularly important given the Pharmaceuticals & Biotechnology sector’s contribution to the Indian economy and healthcare...

Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-24 15:00:42

Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-24 14:00:26

Sun Pharmaceutical Industries has registered a significant rise in open interest within its derivatives segment, reflecting evolving market positioning and investor sentiment. This development comes amid a backdrop of subdued price performance and shifting volume dynamics, offering insights into potential directional bets and trading strategies in the pharmaceutical sector.

Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-24 13:00:19

Sun Pharmaceutical Industries has experienced a significant rise in open interest within its derivatives segment, reflecting evolving market positioning and investor sentiment. This development comes amid a backdrop of recent price fluctuations and shifting volume patterns, offering insights into potential directional bets in the pharmaceutical sector.

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-24 09:21:23

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index places Sun Pharmaceutical Industries under the spotlight of institutional investors and index funds, which often track or benchmark against this key market indicator. The company’s market capitalisation, currently standing at approximately ₹4,21,491 crore, solidifies its status as a large-cap entity within the Pharmaceuticals & Biotechnology sector. This inclusion not only enhances visibility but also influences liquidity and trading volumes, as many passive funds allocate capital in line with the index composition.

Sun Pharmaceutical’s presence in the Nifty 50 also means that its stock performance contributes materially to the overall index mov...

Sun Pharmaceutical Industries: Navigating Market Dynamics as a Nifty 50 Constituent

2025-12-23 09:21:09

Significance of Nifty 50 Membership

Being part of the Nifty 50 index, Sun Pharmaceutical Industries commands considerable attention from institutional investors and fund managers who track this benchmark closely. The company’s large-cap status, with a market capitalisation of approximately ₹4,24,982 crores, places it among the most influential stocks shaping the index’s trajectory. This membership not only enhances liquidity but also ensures that the stock is a key component in passive investment strategies and index funds.

Sun Pharma’s presence in the index reflects its scale and market relevance within the Pharmaceuticals & Biotechnology sector, which is a vital segment of the Indian economy. The sector itself has seen m...

View All News